remdesivir featured image
News Stories

WHO to Set Issue Policy Guidelines on Use of Remdesivir Drug

The World Health Organization is expected to issue policy guidelines on the use of antiviral drug Remdesivir as an emergency use to treat COVID-19 in several countries.

As per the NKA World report, “The WHO announced on Thursday the interim results of a clinical trial which is coordinated that show Remdesivir appears to have little or no effect in preventing death from COVID-19 or reducing time in hospital. The trial was carried out in more than 400 hospitals in 30 countries.”

In a news conference, WHO Director-General Tedros Adhanom Ghebreyesus said that he expects the full results to be published shortly.

According to Chief Scientist of WHO Soumya Swaminathan said she thinks regulatory agencies of countries will reanalyze the trial data and decide whether emergency use should be recommended.

As of now, the WHO said that the steroid Dexamethasone, used to treat pneumonia, is the only drug effective for people seriously-ill with COVID-19, NHK World said.

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS

Send this to a friend